Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.

Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ, Kaplitt MG, Feigin A.

JCI Insight. 2017 Apr 6;2(7):e90133. doi: 10.1172/jci.insight.90133.

2.

Review of methods for determination of total protein and peptide concentration in biological samples.

Sapan CV, Lundblad RL.

Proteomics Clin Appl. 2015 Apr;9(3-4):268-76. doi: 10.1002/prca.201400088. Epub 2015 Mar 16.

PMID:
25641792
3.

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A.

Lancet Neurol. 2011 Apr;10(4):309-19. doi: 10.1016/S1474-4422(11)70039-4.

PMID:
21419704
4.

Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat.

Fitzsimons HL, Riban V, Bland RJ, Wendelken JL, Sapan CV, During MJ.

J Gene Med. 2010 Apr;12(4):385-98. doi: 10.1002/jgm.1449.

5.
6.

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.

Davis GL, Nelson DR, Terrault N, Pruett TL, Schiano TD, Fletcher CV, Sapan CV, Riser LN, Li Y, Whitley RJ, Gnann JW Jr; Collaborative Antiviral Study Group.

Liver Transpl. 2005 Aug;11(8):941-9.

7.

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

Stiehm ER, Fletcher CV, Mofenson LM, Palumbo PE, Kang M, Fenton T, Sapan CV, Meyer WA, Shearer WT, Hawkins E, Fowler MG, Bouquin P, Purdue L, Sloand EM, Nemo GJ, Wara D, Bryson YJ, Starr SE, Petru A, Burchett S.

J Infect Dis. 2000 Feb;181(2):548-54.

PMID:
10669338
8.

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, Hayes D, Louder MK, Brown CR, Sapan CV, Frankel SS, Lu Y, Robb ML, Katinger H, Birx DL.

J Virol. 1999 May;73(5):4009-18.

9.

Colorimetric protein assay techniques.

Sapan CV, Lundblad RL, Price NC.

Biotechnol Appl Biochem. 1999 Apr;29 ( Pt 2):99-108. Review.

PMID:
10075906
10.

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J Jr, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H.

J Infect Dis. 1999 Mar;179(3):567-75.

PMID:
9952362
11.

Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.

Lynch JA, deSouza M, Robb MD, Markowitz L, Nitayaphan S, Sapan CV, Mann DL, Birx DL, Cox JH.

J Infect Dis. 1998 Oct;178(4):1040-6.

PMID:
9806032
12.
13.

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.

Lambert JS, Mofenson LM, Fletcher CV, Moye J Jr, Stiehm ER, Meyer WA 3rd, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A.

J Infect Dis. 1997 Feb;175(2):283-91.

PMID:
9203648
14.

Immunoglobulin stability.

Sapan CV.

Biotechnol Appl Biochem. 1997 Feb;25(1):9-11. No abstract available.

PMID:
9032932

Supplemental Content

Loading ...
Support Center